Hutch News

Hutch News

Stories tagged 'targeted t cell immunotherapy'

What's new in blood diseases

Four things to watch from the 2016 annual meeting of the American Society of Hematology

Dec. 20, 2016 | By Susan Keown / Fred Hutch News Service

For a few days earlier this month, a small city’s-worth of health professionals and researchers from nations across the globe converged for the world’s biggest conference in hematology. Fred Hutch News Service was on the ground at the annual meeting of the American Society of Hematology Dec. 3-6 in San Diego, California. From immunotherapy for advanced blood cancers to new approaches to treating sickle cell disease, here’s our top four things to watch from the meeting.

View story >


Fred Hutch opens first-of-its kind Bezos Family Immunotherapy Clinic

Clinic will allow researchers to conduct twice as many immunotherapy trials, enable intensive patient monitoring to improve experimental therapies

Nov. 1, 2016 | By Fred Hutch News Service

The new clinic will allow researchers to conduct twice as many immunotherapy trials and enable intensive patient monitoring to improve experimental therapies.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

March 25, 2016

Drs. Ruth Etzioni and Joshua Roth lead economic analysis of PSA screening and selective treatment strategies for prostate cancer; this and more Good News at Fred Hutch.

View story >


Fred Hutch at ASCO

Research highlights from the annual meeting of the American Society of Clinical Oncology

May 29, 2015 | By Fred Hutch News Service staff

A number of investigators from Fred Hutch will share new research findings at the annual meeting of the American Society of Clinical Oncology, or ASCO, which is being held today through June 2 in Chicago. The theme of this year’s gathering is “Illumination & Innovation: Transforming Data into Learning.”

View story >


The right tools for the job: taking immunotherapy to the next level

Dr. Matthias Stephan is combining the fields of immunology, bioengineering and gene therapy to harness the immune system to treat solid tumors

May 22, 2015 | By Dr. Sabrina Richards / Fred Hutch News Service

Dr. Matthias Stephan is a pioneer in the field of immunobioengineering, working where “materials science meets immunology” to create unconventional solutions to treating cancer. He is devising inventive strategies to circumvent the hurdles that prevent immunotherapy from being cost-effective, widely available and effective against many types of cancer.

View story >


'A tidal wave coming': Xconomy Forum focuses on promising treatments

Immunotherapy a key topic at sold-out discussion on the role of biotech in Seattle

May 7, 2015 | By Bill Briggs / Fred Hutch News Service

The word “cure” has long been overused, but the promise of immunotherapy as an anti-cancer weapon means it’s indeed the right time to start using it, said Dr. D. Gary Gilliland, president and director of Fred Hutch, at an Xconomy Forum held at the Hutch on Wednesday.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.